CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services. In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves. Read More
Synergy CHC Corp. (NASDAQ: SNYR) is capturing national attention with the announcement of a strategic distribution partnership with McKesson Canada, a division of McKesson Corporation (NYSE: MCK) . The agreement gives FOCUSfactor® direct access to thousands of pharmacies and health-focused retailers across Canada, igniting the next phase of its aggressive North American expansion.
Backed by $1 million in funding from the CVS Health Foundation, the pilot initiative offers free, virtual health screenings to support aging with confidence, care, and convenience Health checks include assessments for heart health, memory, cognitive function, and mental health No travel required — all appointments are virtual and confidential Community Health Workers provide […]
Backed by $1 million in funding from the CVS Health Foundation, the pilot initiative offers free, virtual health screenings to support aging with confidence, care, and convenience
PALM BEACH, Fla., July 10, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The global telehealth market has been substantially growing over the past years and is expected to continue this growth well into the future. A report from Grand View Research said that: “The global telehealth market size was estimated at USD 123.26 billion in 2024 and is projected to reach USD 455.27 billion by 2030, growing at a CAGR of 24.68% from 2025 to 2030. North America dominated the telehealth market with the revenue share of 46.58% in 2024. The market is primarily driven by the increasing adoption of digital health & smartphones, rising investments, improved internet connectivity, and growing technological advancements… the growing adoption and acceptance of telehealth services are expected to boost the market's growth over the forecast period.” The report continued: “Moreover, smartphones have evolved from devices of communication & entertainment to devices that can monitor health and fitness. Some market players are developing Chatbot services for basic medical inquiries and one-time consultations… Moreover, the market is propelled by favorable government initiatives to expand telehealth by making healthcare services more accessible and convenient for patients. The focus on cost-effective and efficient healthcare solutions further propels the adoption of telehealth services. The rising adoption of telehealth facilities by patients, physicians, and government authorities is boosting the market. Access to healthcare through specific applications and video consultations enables communication between patients and doctors in remote locations, eliminating the need to visit hospitals or clinics. Market players such as Apple, Google, and IBM focus on improving the mobile health experience by providing numerous solutions through different subscription plans and emphasizing data security. These factors are expected to drive the market growth over the forecast period.” Active tech companies in the markets this week include Treatment AI, Inc. (OTCQB: TREIF) (CSE: TRUE), CVS Health® (NYSE: CVS), Teladoc Health, Inc. (NYSE: TDOC), Tempus AI, Inc. (NASDAQ: TEM), Hims & Hers Health, Inc. (NYSE: HIMS).
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at CVS Health (NYSE:CVS) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Oscar Health (NYSE:OSCR) and the best and worst performers in the health insurance providers industry.
Synergy CHC Corp. (NASDAQ: SNYR) has surged over 74% in the last 30 days, fueled by the execution of a sweeping retail expansion strategy for its flagship FOCUSfactor® brand, now available in both supplement and functional beverage form. The brand’s rollout to over 50,000 locations —via Core-Mark, Walmart Canada, Metro Ontario, and Downey Wholesale—marks a major milestone, unlocking national reach across mass retail, grocery, convenience, and independent channels.
Synergy CHC Corp. (NASDAQ: SNYR), a rising consumer staple health company, has announced a wave of major expansion throughout North American for its FOCUSfactor® supplements and functional beverage brands, across mass, grocery, convenience, and wholesale channels. Functional Beverage Momentum
The case stems from a whistleblower lawsuit filed by a former Aetna actuary who alleged CVS Caremark manipulated drug pricing to inflate Medicare claims while underpaying pharmacies.
Each stock in this article is trading near its 52-week high.
These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
